December 22, 2021
Trial data found that the therapy could reduce the risk of hospitalization and death in high-risk patients by around 80 percent.
China’s antibody therapy against Covid-19 could be in use soon
Trial data found that the therapy could reduce the risk of hospitalization and death in high-risk patients by around 80 percent.
